Terazosin Hydrochloride

CHEMBL3989562 Phase 4 Zugelassen Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

459.9 g/mol

LogP

—

Phase

4

A hydrochloride salt form of terazosin with the same therapeutic properties. This medication relaxes the muscles in blood vessel walls and the prostate, and is used to treat high blood pressure and the urinary symptoms of an enlarged prostate (BPH).

Molekularmasse

459,9000 g/mol

TPSA

105,00 Å²

Therapeutische Bereiche

Benign Prostatic Hyperplasia Cardiovascular Disease Parkinson's Disease Stroke Type 2 Diabetes Hypertension Atrial Fibrillation

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D-Struktur

SVG PNG

Cite this structure

Embed this structure

SMILES

COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC.Cl.O.O

InChI

InChI=1S/C19H25N5O4.ClH.2H2O/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14;;;/h10-11,14H,3-9H2,1-2H3,(H2,20,21,22);1H;2*1H2

Molecular Formula

C19H30ClN5O6

HBD / HBA

4 / 10

Rotierbare Bindungen

4

Schwere Atome

31

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Häufig gestellte Fragen

A hydrochloride salt form of terazosin with the same therapeutic properties. This medication relaxes the muscles in blood vessel walls and the prostate, and is used to treat high blood pressure and the urinary symptoms of an enlarged prostate (BPH).

Yes, Terazosin Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL3989562. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 63016. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Suchen Sie patientenfreundliche Informationen?

Terazosin Hydrochloride auf PillFYI

Struktur

Schnelldaten

Formel: C19H30ClN5O6
Synonyme: 1

Externe Links

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Medizinischer Haftungsausschluss

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.